Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Tuberculosis Vaccine Initiative
This publication has 32 references indexed in Scilit:
- TuberculosisNew England Journal of Medicine, 2013
- Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic TreatmentThe Journal of Infectious Diseases, 2012
- Mycobacterium vaccae as Adjuvant Therapy to Anti-Tuberculosis Chemotherapy in Never-Treated Tuberculosis Patients: A Meta-AnalysisPLOS ONE, 2011
- Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic ReviewPLOS ONE, 2011
- A multistage tuberculosis vaccine that confers efficient protection before and after exposureNature Medicine, 2011
- Landscape and children’s health: Old natures and new challenges for the preventoriumHealth & Place, 2011
- Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative ResearchPLOS Medicine, 2007
- The history of tuberculosisRespiratory Medicine, 2006
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Cytokines and the Koch phenomenonTubercle, 1991